EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees

原文：2020年发布于 European Urology 77卷第2期 223-250  浏览量：335次 原文链接

作者： European Association of Urology European Society for Medical Oncology

归属分类：膀胱肿瘤临床实践指南

关键词： Bladder Cancer Management Consensus

文献简介

无

原文网址：https://pubmed.ncbi.nlm.nih.gov/31753752/

Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges

膀胱浸润性尿路上皮癌PD-L1(SP263)免疫组织化学检测病理专家共识

热门文献

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

 Clin Invest Med 1171
Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

 J Cancer Res Ther 39 卷第 6 期 844
吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

 PeerJ 60 卷第 5 期 800
Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

 Int J Nurs Pract 13 卷第 4 期 753
Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

 Bmc Urology 714
Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

 Oncotarget 669
膀胱癌标本规范化处理和病理诊断共识

 中华病理学杂志 49卷第4期 669
Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

 Eur J Nutr 11 卷第 2 期 666
Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

 International Journal of Urology 661
[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

 Front Endocrinol (Lausanne) 13 卷第 11 期 651

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees

原文：2020年发布于 European Urology 77卷第2期 223-250  浏览量：335次 原文链接

文献简介

上一篇

Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges

下一篇

膀胱浸润性尿路上皮癌PD-L1(SP263)免疫组织化学检测病理专家共识

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

膀胱癌标本规范化处理和病理诊断共识

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees

原文：2020年 发布于 European Urology 77卷 第2期 223-250  浏览量：335次 原文链接

文献简介

上一篇

下一篇

原文：2020年发布于 European Urology 77卷第2期 223-250  浏览量：335次 原文链接